Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Sex Transm Infect. 2013 Jan 26;89(6):504–508. doi: 10.1136/sextrans-2012-050946

Trichomonas vaginalis infection in men who submit self-collected penile swabs after internet recruitment

Charlotte A Gaydos 1, Mathilda R Barnes 1, Nicole Quinn 1, Mary Jett-Goheen 1, Yu-Hsiang Hsieh 1
PMCID: PMC3748226  NIHMSID: NIHMS473232  PMID: 23354525

Abstract

Background

Submission of self-collected penile samples collected at home could remove barriers that men face in getting tested for sexually transmitted infections (STIs).

Methods

From December 2006 to July 2012, sexually active men aged ≥14 years were recruited by an educational internet program (http://www.iwantthekit.org) which offered free testing for Trichomonas vaginalis infection. Kits were ordered online and swabs were sent via US mail to the laboratory and tested by nucleic acid amplification tests. Demographics and sexual risk factors were accessed by questionnaires. Men called or were contacted to receive their results. Risk factors for trichomonas infection were determined by multivariate logistic regression

Results

Of 4398 men requesting kits, 1699 (38.6%) returned swabs by mail (55.4% returned in 2012). Forty-one percent of men were aged <25 years, 43% were black subjects and 45% were white. The overall prevalence for trichomonas in the 1699 men was 3.7%; the highest prevalence by age group was for men aged 40–49 years (5.2%) and, by year, 216 men screened in 2008 had the highest prevalence (12.5%). Risk factors for 919 men whose risk information was collected by questionnaire (prevalence 6.0%) indicated that 9.6% had a concurrent chlamydia infection. Significantly associated risks factors included: black race (adjusted OR 2.67), residence in Illinois (OR 12.02), age 30–39 years (OR 6.63) and age >40 years (OR 5.31).

Conclusions

A fairly high prevalence of trichomonas and sexual risk factors were demonstrated from internet recruitment of men. This method of engaging men to get screened for trichomonas may augment screening in STI clinics.

INTRODUCTION

Trichomonas infections caused by Trichomonas vaginalis (TV) are highly prevalent sexually transmitted infections (STIs) worldwide, with estimates of 7–8 million infections annually in the USA and 180 million globally.1 They represent the most common curable STI in young sexually active men and women.2,3 However, few data are available for men. Miller et al4 reported the prevalence of trichomonas in men aged 18–26 years in the National Longitudinal Study of Adolescent Health cohort as 1.7%.

Trichomonas infections in women have been associated with poor reproductive outcomes such as low birth weight (LBW) and premature birth.5,6 Among 13 000 women, there was an attributable risk of trichomonas associated with LBW in black subjects of 11% compared with 1.6% in Hispanic subjects and 1.5% in white women.5 The National Health and Nutrition Examination Survey (NHANES) 2001–2004 estimated that 3.1% of women in the USA have TV.7 Data from NHANES also demonstrated that TV was associated with other STIs among women in the civilian US population in a sample of 3648 women representing a weighted sample of the experience of 65 563 298 women aged 14–49 years.8 The prevalence of trichomoniasis was 3.2%, with >80% of cases being asymptomatic. Public health wisdom assumes that men are the reservoir for trichomonas infections in women and vice versa.

More data and improved methods are needed to screen men for trichomonas. Submission of self-obtained penile samples collected at home could increase screening, as well as removing barriers that men face in getting tested for STIs. The purpose of this study was to provide trichomonas testing by nucleic acid amplification tests (NAATs) in men using self-collected penile-meatal swabs after internet recruitment to determine the prevalence and to ascertain risk factors associated with trichomoniasis.

METHODS

Sexually active men aged ≥14 years were recruited by an internet program (http://www.iwantthekit.org) which was educational for STIs and offered free testing from self-collected penile-meatal samples for trichomonas, chlamydia and gonorrhea from December 2006 to July 2012. Specific directions for sample collection were provided in each kit and on the website. The study was approved by the Institutional Review Board (IRB) with written consent. Kits were supplied free by ordering from the website with an option of a toll-free phone call. Swab samples were returned by mail in preaddressed postage-paid mailers to the testing laboratory. This program was active in Maryland, the District of Columbia, West Virginia, selected counties in Illinois, Denver Colorado and Alaska. Testing was performed by NAAT, APTIMA TV, analyte specific reagent assay (Gen-Probe, San Diego, California, USA). This assay is now cleared by the Food and Drug Administration for women (not men) and is commercially available.9

Men were instructed to call for results in 1–2 weeks and to give a preferred method (email, cell phone, letter or, recently, text message) for notification of results if they forgot to call. Infected men were offered free treatment at participating clinics.

Demographic characteristics and risk factors for trichomonas infection were accessed by self-administered questionnaires, which could be completed online or within the kit. Questionnaires and consent forms were discontinued in February 2011 in an effort to increase participation in the program, with IRB approval to designate the program as ‘public health’ and no longer ‘research’.

Questionnaire data missing for each variable ranged from 0.3% to 18.2%; most were <10% except for ethnicity, individual/ household income, health insurance and condom usage during oral sex or anal sex. Multiple imputation technique for missing values was performed in order to eliminate the bias due to dropping records with missing values. χ2 tests were performed for bivariate analysis and logistic regression was performed using SAS V.9.3 (SAS Institute, Cary, North Carolina, USA) followed by multiple imputation. p Values of <0.05 were considered significant. Variables with a p value <0.2 in bivariate analysis and other variables a priori considered as potential important confounders were entered into a full multiple logistic regression model for stepwise model selection approach for a final multivariate regression model.

RESULTS

A total of 1699 men requested kits and returned swabs by mail. Almost no kits were requested by telephone. The overall return rate for requested kits was 38.6%, with 55.4% in 2012; 9.1% were aged <20 years, 32.3% were 20–24 years, 20.7% were 25–29 years and 22.4% were 30–39 years (table 1). Almost half (44.9%) were white subjects and 42.7% were black; 68.6% were from Maryland (table 1). The prevalence of trichomonas was 3.7% overall. Figure 1 demonstrates the prevalence of TV infection by year in the 1699 men in the internet screening program. The prevalence was higher in 2008 than in other years (p<0.05). All men except one received treatment in participating clinics.

Table 1.

Prevalence of Trichomonas vaginalis infection by demographics in 1699 male participants in the internet screening program

Characteristics Categories Number
(n=1699)
Number (%)
positive
Overall 1699 62 (3.7)
Age (years) <20 155 3 (1.9)
21–24 548 23 (4.2)
25–29 351 11 (3.1)
30–39 381 15 (3.9)
40–49 153 8 (5.2)
≥50 91 2 (2.2)
Unknown 20 0 (0.0)
Race* Black 726 43 (5.9)
Asian 43 0 (0.0)
Native Hawaiian 7 0 (0.0)
Native American 15 0 (0.0)
White 763 16 (2.1)
Multirace 53 1 (1.9)
Other 76 2 (2.6)
Unknown 16 0 (0.0)
Ethnicity* Hispanic 111 0 (0.0)
Non-Hispanic 1526 56 (3.7)
Unknown 62 6 (9.7)
Calendar year* 2007 143 3 (2.1)
2008 216 27 (12.5)
2009 369 21 (5.7)
2010 154 3 (2.0)
2011 468 4 (0.9)
2012 349 4 (1.2)
Residential area* Alaska 72 0 (0.0)
Maryland (Baltimore City) 336 31 (3.7)
Maryland (other) 829 12 (3.6)
District of Columbia 71 1 (1.4)
Colorado 149 5 (3.4)
Illinois 81 8 (9.9)
West Virginia 105 0 (0.0)
Other 7 0 (0.0)
Unknown 49 5 (10.2)
*

p<0.05.

Calendar year 2007 includes 19 individuals participating in late 2006; calendar year 2012 includes participants from 1 January 2012 to 31 July 2012.

Figure 1.

Figure 1

Prevalence of Trichomonas vaginalis infection in 1699 men who participated in the internet screening program.

One thousand and nineteen participants completed questionnaires before they were discontinued and were included in the bivariate and multivariate analysis of the behavioural risk questionnaires. The prevalence of trichomonas was 6% (table 2); 11% of men were aged <20 years, 36.1% were 20–24 years, 20.2% were 25–29 years and 20.4% were 30–39 years; 46.4% were white subjects and 43.9% were black; 76.8% were single. No symptoms were reported by 56.6% and 10.3% reported penile discharge (table 2). Concurrent infection with chlamydia was demonstrated in 13.6% and with gonorrhoea in 1.3%. Bivariate analysis indicated race, ethnicity, age at first sex, calendar year of screening, participant’s sex partner’s sexual identification and urogenital symptoms were significantly associated with trichomonas infection (table 2).

Table 2.

Bivariate analysis of Trichomonas vaginalis infection status on risk factors for infection in men who participated in the internet-based screening program (N=919).

Risk factor Characteristic N T vaginalis
prevalence (%)
Overall 919 55 (6.0)
Age (years) 15–19 101 2 (2.0)
20–24 332 22 (6.6)
25–29 186 8 (4.3)
30–39 187 15 (8.0)
40–49 78 6 (7.7)
≥50 35 2 (5.7)
Race* White 426 15 (3.5)
Black 403 37 (9.2)
Asian 17 0 (0.0)
Other 70 3 (4.3)
Missing 3 0 (0.0)
Ethnicity* Hispanic 69 0 (0.0)
Non-Hispanic 811 49 (6.0)
Missing 105 6 (15.4)
Calendar year* 2006–2007 143 3 (2.1)
2008 216 27 (12.5)
2009 369 21 (5.7)
2010 154 3 (2.0)
2011 37 1 (2.7)
State West Virginia 78 0 (0.0)
Maryland 392 24 (6.1)
Baltimore 190 12 (6.3)
District of Columbia 32 1 (3.1)
Illinois 68 8 (11.8)
Colorado 110 5 (4.6)
Other states 2 0 (0.0)
Missing 47 5 (10.6)
Marital status Single 706 45 (6.4)
Married 72 3 (4.2)
Separated 22 1 (4.6)
Divorced 47 1 (2.1)
Missing 72 5 (6.9)
Income <$10000 113 12 (10.6)
$10000–$49999 459 28 (6.1)
$50000–$99999 150 6 (4.0)
>$100000 29 0 (0.0)
Missing 168 9 (5.4)
Health insurance With 430 18 (4.2)
Without 393 30 (7.6)
Missing 96 7 (7.3)
Education Less than high school 46 1 (2.2)
High school 265 20 (7.6)
Community college 114 7 (6.1)
Some college 152 10 (6.6)
Bachelors 179 7 (3.9)
Masters 50 0 (0.0)
Doctoral 8 1 (12.5)
Other 29 2 (6.9)
Missing 76 7 (9.2)
Age had first sex (years)* 5–9 10 2 (20.0)
10–14 219 18 (8.2)
15–19 531 25 (4.7)
20–24 61 1 (1.6)
≥25 9 0 (0.0)
Missing 89 9 (10.1)
Number of partners in the last year None 15 1 (6.7)
1 208 13 (6.3)
2–4 405 23 (5.7)
5–9 153 11 (7.2)
10–15 43 0 (0.0)
≥16 31 1 (3.2)
Missing 64 6 (7.6)
New partner within past 3 months No 405 27 (6.7)
Yes 450 22 (4.9)
Missing 64 6 (9.4)
>1 partner last 3 months No 533 32 (6.0)
Yes 320 17 (5.3)
Missing 66 6 (9.1)
Partner’s sex* Men only 80 0 (0.0)
Women only 750 48 (6.4)
Men and women 32 1 (3.1)
Missing 57 6 (10.5)
Vaginal sex No 64 0 (0.0)
Yes 792 49 (6.2)
Missing 63 6 (9.5)
Oral sex No 37 3 (8.1)
Yes 826 47 (5.7)
Missing 56 5 (8.9)
Anal sex No 375 17 (4.5)
Yes 485 32 (6.6)
Missing 59 6 (10.2)
Condom use with vaginal sex Always 114 5 (4.4)
Most of the time 340 14 (4.1)
Some of the time 271 17 (6.3)
Never 136 14 (10.3)
Missing 58 5 (8.6)
Condom use with oral or anal sex Always 66 2 (3.0)
Most of the time 142 6 (4.2)
Some of the time 178 12 (6.7)
Never 373 24 (6.4)
Missing 160 11 (6.9)
Drink before sex No 244 17 (7.0)
Yes 599 33 (5.5)
Missing 76 5 (6.6)
Ever tested for STI No 327 19 (5.8)
Yes 480 31 (6.5)
Don’t know 25 0 (0.0)
Missing 87 5 (5.8)
Ever treated for STI No 543 27 (5.0)
Yes 303 22 (7.3)
Don’t know 11 0 (0.0)
Missing 62 6 (9.7)
Partner had STI No 155 13 (8.4)
Yes 271 15 (5.5)
Don’t know 436 22 (5.1)
Missing 57 5 (8.8)
Having trichomoniasis in the past No 790 47 (6.0)
Yes 56 2 (3.6)
Missing 73 6 (8.2)
Urogenital symptoms None 520 29 (5.6)
Penile discharge* 95 11 (11.6)
Pain during urination 116 5 (4.3)
Penis itching 110 7 (6.4)
Rash/ulcers/sores 54 3 (5.6)
Pain during intercourse 18 1 (5.6)
Groin/testes pain 85 5 (5.9)
Missing 81 7 (8.6)
Concurrent chlamydial infection* No 794 43 (5.4)
Yes 125 12 (9.6)
Concurrent gonococcal infection No 907 54 (6.0)
Yes 12 1 (8.3)
*

p<0.05.

Not mutually exclusive.

US Dollars.

STI, sexually transmitted infections.

Multivariate analysis for trichomonas infection indicated the following significant (p<0.05) risk factors: black race (OR 2.7), any age 30 years or older (OR age 30–39 years 6.63; OR age >40 years 5.31), residence in Illinois (OR 12.0), age of first sex <15 years (OR 1.8) and penile discharge (OR 2.3) (table 3).

Table 3.

Risk factors associated with prevalence of Trichomonas vaginalis infection in 919 men who participated in the internet screening program*

Characteristics Categories OR (95% CI)
Age (years) <20 1.00
20–24 4.39 (0.99 to 19.34)
25–29 3.31 (0.67 to 16.28)
30–39 6.63 (1.45 to 30.35)
≥40 5.31 (1.06 to 26.46)
Race African-American 2.67 (1.38 to 5.12)
Other 1.00
Residential state Illinois 12.02 (1.14 to 127.11)
Maryland and DC 3.71 (0.39 to 35.48)
Colorado, West Virginia 1.00
Age when first having sex (years) <15 1.82 (1.00 to 3.33)
≥15 1.00
Urogenital symptom (penis discharge) Yes 2.25 (1.03 to 4.89)
No 1.00
*

Multivariate logistic regression after performing multiple imputation procedure for missing data.

DISCUSSION

Our internet-recruited population demonstrated a fairly high prevalence of trichomonas among men who submitted penile-meatal swabs self-collected at home, similar to a previously reported high prevalence of trichomonas in women in the program.10 Age was not associated with trichomonas infection in that study, although other studies have associated trichomonas infection with older age in women.4,11 In the current study, trichomonas infections were associated with older age in men. These data underscore the significance of prevalent trichomonas infections in older men, since the OR for men aged ≥40 years compared with men aged <20 years was 5.31. The highest OR was for men aged 30–39 years (OR 6.63). More trichomonas infection in older men may contribute to the reported higher rates of trichomoniasis in older women as well.11

We cannot explain the higher prevalence in 2008 compared with other years. Fewer men were screened that year, but this does not appear to explain the 2008 prevalence spike. Similarly puzzling is the overall prevalence of trichomonas of 3.7% in the 1699 men for all years compared with a prevalence of 6.0% for the earlier time periods before the questionnaires were discontinued. Questionnaires were discontinued in early 2011 along with the consent form in an effort to improve volunteer rates, which did appear to improve participation rates. More at-risk non-symptomatic men may have decided to participate when there were fewer requirements for consent forms and questionnaires, which could have led to a lower prevalence overall whereas men who were symptomatic and more likely to be infected may have taken the time to fill out the required forms in the earlier years.

Black race was significantly associated with trichomonas infection in the female internet study (OR 2.69) with a prevalence of 13.2% compared with 5.6% in white subjects.4,7,11 Similarly, in this study of trichomonas infection in men, black race was also statistically associated with trichomoniasis (OR 2.67).

Demographic factors showed that nearly half (46.8%) of men had insurance, that 76.8% were single and 5% had less than a high school education, with many having at least a college degree (25.8%) and 49.9% having an income of $10 000–49 999/year. Taken together, one could postulate that many of these men could have attended clinics for the diagnosis of trichomoniasis or other STIs. However, if such infections are asymptomatic or only mildly symptomatic, they may not attend the clinics. Home collection of genital samples appears to be a highly desirable and convenient method for screening for STIs, at least in women1215 in whom it has been shown to be potentially cost saving.16,17 Further study will be required to establish whether internet recruitment and home collection will facilitate more testing and more treatment for prevalent trichomonas and other STIs in men.

We acknowledge that a limitation of our study was that only 38.6% of men who ordered kits returned them, so we are unable to estimate the acceptability of collecting penile-meatal swab samples at home to those men who did not return the kits. One caveat is that the return rate has improved over time, especially after the requirements for a consent form and questionnaire were dropped. The return rate for men was only 15.3% in 2006 but increased to 55.4% in 2012. Uptake in our comparable women’s study in 2012 was approximately the same (50.2%). A home screening randomised controlled trial in women for chlamydia and gonorrhoea demonstrated that home screening was acceptable to women and showed that women who received a home testing intervention option completed significantly more STI tests overall.15 Another study has reported that 75.7% of women given a choice in a 1-year follow-up contraceptive study that screened for STIs chose the home collection method over visiting a clinic or their own doctor.14 The authors recommended that future interventions to increase screening for STIs should consider home-based or patient-controlled testing.14 As a result of our study in men, we believe that home testing for trichomonas, as well as for chlamydia and gonorrhoea, should be recommended for men as another option to clinic-based testing to increase STI testing rates. Whether the internet method will translate into increased male testing through home collection is unknown at present, but an earlier study comparing urine with penile-meatal swab testing found high acceptability for home collection of either sample type in men.18

While 56.6% of men reported no symptoms in our study (prevalence 5.6%), only 10.3% reported penile discharge but their prevalence for trichomonas was 11.6%; 12.6% reported pain during urination and had a prevalence of 4.3%. As other STIs such as chlamydia and gonorrhoea were also being tested and were also prevalent, it is uncertain which symptoms were only due to trichomonas infection. It is interesting that in multivariate analysis in our study that penile discharge was associated with trichomoniasis, in addition to black race and age ≥30 years. The association of trichomonas infection with older age in men is not fully understood, but is similar to studies in women.4,9 The association of trichomonas infection with black race has been well documented in women.4,9,10

Recruitment via the internet and self-collection of samples at home may facilitate easy public health screening for trichomonas and internet programs can also be educational. Many public health officials say we cannot continue to ignore trichomonas infections.1920 Many recent reports have associated TV with HIV transmission and acquisition; most have been for women.6,2123 Recent studies have demonstrated that the estimated annual number of new HIV transmissions in the USA attributable to a trichomonas cofactor effect may represent a 2–5-fold increased risk.24,25 Anderson et al26 demonstrated that treatment for trichomonas can reduce the genital HIV shedding burden in women who were not receiving antiretroviral therapy The increasing associations with HIV make a public health initiative for trichomonas difficult to ignore. New optimal prevention, diagnosis and control strategies for trichomonas are imperative for men, as well as for women, and may have the ability to decrease racial differences due to these infections.7

Evidence from a recent clinical trial for home versus clinic-based screening for STIs demonstrated that men were 60% more likely to complete screening if they were assigned to home-based screening.27

In summary, we have demonstrated that internet recruitment and self-collection of penile-meatal specimens can serve as another tool in expanding public health screening for trichomonas, and that men who use such a program have a moderately high prevalence of trichomonas.

Key messages.

  • A fairly high prevalence of trichomonas (3.7–6%) and high sexual risk factors were demonstrated from internet recruitment of men for screening by home collection of penile-meatal samples.

  • The highest prevalence of trichomonas was observed in men aged 30–49 years.

  • Reaching men by internet recruitment to get screened for trichomonas may augment screening in STI and other clinics.

  • It will be important to screen and treat men for trichomonas infections, as well as women.

Acknowledgments

Funding U54EB007958, NIBIB, NIH; AI068613-01, NIH, NIAI.

Footnotes

Contributors CG designed the study and prepared the manuscript; MB collected data and managed kits and treatment; NQ tested the samples and contributed to manuscript preparation; MJ-G managed data and contributed to manuscript preparation; Y-HH developed data analysis master plan, provided statistical analysis and contributed to manuscript preparation.

Competing interests None.

Patient consent Obtained.

Ethics approval Johns Hopkins University.

Provenance and peer review Commissioned; externally peer reviewed.

REFERENCES

  • 1.WHO. Trichomonas. Geneva, Switzerland: World Health Organization; 2010. [accessed 15 Nov 2012]. http://www.who.int/reproductivehealth/publications/rtis/2008_STI_estimates.pdf. [Google Scholar]
  • 2.Van Der Pol B, Williams JA, Orr DP, et al. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. J Infect Dis. 2005;192:2039–2044. doi: 10.1086/498217. [DOI] [PubMed] [Google Scholar]
  • 3.Weinstock H, Berman S, Cates W. Sexually transmitted disease among American youth: incidence and prevalence estimates. Perspect Sex Reprod Health. 2004;36:6–10. doi: 10.1363/psrh.36.6.04. [DOI] [PubMed] [Google Scholar]
  • 4.Miller WC, Swygard H, Hobbs MM, et al. The prevalence of trichomoniasis in young adults in the United States. Sex Transm Dis. 2005;32:593–598. doi: 10.1097/01.olq.0000179874.76360.ad. [DOI] [PubMed] [Google Scholar]
  • 5.Cotch MF, Pastorek JG, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Transm Dis. 1997;24:353–360. doi: 10.1097/00007435-199707000-00008. [DOI] [PubMed] [Google Scholar]
  • 6.Schwebke JR, Burgess D. Trichomoniasis. Clin Microbiol Rev. 2004;17:794–803. doi: 10.1128/CMR.17.4.794-803.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Sutton M, Sternberg M, Koumans EH, et al. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001–2004. Clin Infect Dis. 2007;45:1319–1326. doi: 10.1086/522532. [DOI] [PubMed] [Google Scholar]
  • 8.Allsworth JE, Ratner JA, Peipert JF. Trichomonas and other sexually transmitted infections: results from the 2001–2004 National Health and Nutrition Examination Surveys. Sex Transm Dis. 2009;36:738–744. doi: 10.1097/OLQ.0b013e3181b38a4b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Schwebke JR, Hobbs M, Taylor S, et al. Molecular testing for Trichomonas vaginalis in women: results of a pivotal US clinical trial. J Clin Microbiol. 2011;49:4106–4111. doi: 10.1128/JCM.01291-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Gaydos CA, Hsieh Y-H, Barnes M, et al. Trichomonas vaginalis infection in women who submit self-collected vaginal samples after internet recruitment. Sex Transm Dis. 2011;38:828–832. doi: 10.1097/OLQ.0b013e3182228911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Helmes DJ, Mosure DJ, Metcalf CA, et al. Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted diseases clinics. Sex Transm Dis. 2008;35:484–488. doi: 10.1097/OLQ.0b013e3181644b9c. [DOI] [PubMed] [Google Scholar]
  • 12.Serlin M, Shafer MA, Tebb K, et al. What sexually transmitted disease screening method does the adolescent prefer? Adolescents’ attitudes towards first-void urine, self-collected vaginal swab, and pelvic examination. Arch Pediatr Adolesc Med. 2002;156:588–591. doi: 10.1001/archpedi.156.6.588. [DOI] [PubMed] [Google Scholar]
  • 13.Hoebe CJPA, Rademaker CW, Brouwers EEHG, et al. Acceptibility of self-taken vaginal swabs and first-catch urine samples for the diagnosis of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae with an amplified DNA assay in young women attending a public health sexually transmitted disease clinic. Sex Transm Dis. 2006;33:491–495. doi: 10.1097/01.olq.0000204619.87066.28. [DOI] [PubMed] [Google Scholar]
  • 14.Grasek AA, Secura GM, Allsworth JE, et al. Home-screening compared with clinic-based screening for sexually transmitted infections. Obstet Gynecol. 2010;115:745–752. doi: 10.1097/AOG.0b013e3181d4450d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Cook RL, Ostergaard L, Hillier SL, et al. Home screening for sexually transmitted diseases in high risk young women: randomized controlled trial. Sex Transm Infect. 2007;83:285–291. doi: 10.1136/sti.2006.023762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Smith KJ, Cook RL, Ness RB. Cost comparisons between home- and clinic-based testing for sexually transmitted diseases in high-risk young women. Infect Dis Obstet Gynecol. 2007;62467 doi: 10.1155/2007/62467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Huang W, Gaydos CA, Barnes M, et al. Cost-effectiveness analysis of Chlamydia trachomatis screening via internet-based self-collected swabs compared to clinic-based sample collection. Sex Transm Dis. 2011;38:815–820. doi: 10.1097/OLQ.0b013e31821b0f50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Chai SJ, Aumakham B, Barnes M, et al. Internet-based screening for sexually transmitted infections to reach nonclinic populations in the community: risk factors for infection in men. Sex Transm Dis. 2010;37:756–763. doi: 10.1097/OLQ.0b013e3181e3d771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Van Der Pol B. Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention. Clin Infect Dis. 2007;44:23–25. doi: 10.1086/509934. [DOI] [PubMed] [Google Scholar]
  • 20.Schwebke JR. Trichomoniasis in adolescents: a marker for the lack of a public health response to the epidemic of sexually transmitted diseases in the United States. J Infect Dis. 2005;192:2036–2038. doi: 10.1086/498221. [DOI] [PubMed] [Google Scholar]
  • 21.Van Der Pol B, Kwok C, Pierre-Louis B, et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis. 2008;197:548–554. doi: 10.1086/526496. [DOI] [PubMed] [Google Scholar]
  • 22.Miller M, Liao Y, Gomez A, et al. Factors associated with the prevalence and incidence of Trichomonas vaginalis infection among African American women in New York City who use drugs. J Infect Dis. 2008;197:503–509. doi: 10.1086/526497. [DOI] [PubMed] [Google Scholar]
  • 23.Kissinger P, Amadee A, Clark RA, et al. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis. 2009;36:11–16. doi: 10.1097/OLQ.0b013e318186decf. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Shafir SC, Sorvillo FJ, Smith L. Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans. Clin Microbiol Rev. 2009;22:37–45. doi: 10.1128/CMR.00002-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Chesson HW, Blandford JM, Pinkerton SD. Estimates of the annual number and cost of new HIV infections among women attributable to trichomoniasis in the United States. Sex Transm Dis. 2004;31:547–551. doi: 10.1097/01.olq.0000137900.63660.98. [DOI] [PubMed] [Google Scholar]
  • 26.Anderson BL, Firnhaber C, Liu T, et al. Effect of trichomoniasis therapy on genital HIV viral burden among African women. Sex Transm Dis. 2012;39:638–642. doi: 10.1097/OLQ.0b013e31825725ad. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Reagan MM, Xu H, Shih SL, et al. A randomized trial of home versus clinic-based sexually transmitted disease screening among men. Sex Transm Dis. 2012;39:842–847. doi: 10.1097/OLQ.0b013e3182649165. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES